Jefferies Group LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 13, 2020	SELL	$17.61 - $31.86 $295,848 - $535,248	-16,800 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $215,250 - $399,600	-15,000 Reduced 47.17%	16,800 $431,000
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $25.6 Million - $68.9 Million	-2,080,000 Reduced 98.49%	31,800 $489,000
Q4 2019 Feb 13, 2020	BUY	$7.26 - $38.49 $14 Million - $74.4 Million	1,932,900 Added 1080.44%	2,111,800 $72.5 Million
Q3 2019 Nov 13, 2019	BUY	$7.47 - $14.03 $925,533 - $1.74 Million	123,900 Added 225.27%	178,900 $1.34 Million
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $585,750 - $785,950	55,000 New	55,000 $714,000
Q4 2017 Feb 14, 2018	SELL	$14.27 - $16.79 $1.71 Million - $2.01 Million	-120,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $1.29 Million - $2.65 Million	120,000	120,000 $1.89 Million

379

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.79B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.